Semaglutide Uses, Dosage, Side Effects and Interactions
Rybelsus
Rybelsus came a year after Ozempic (September 2019) as a tablet. No generic is listed as tablets.
Ozempic
Ozempic was the first semaglutide product the FDA approved, in December 2017. No generic is listed as injections and tablets.
Wegovy
Wegovy came 3 years after Ozempic (June 2021). No generic is listed as injections and tablets.
Semaglutide is a GLP-1 receptor agonist used to improve blood sugar control and lower heart and kidney risks in adults with type 2 diabetes, and to reduce excess body weight, heart risk and, with Wegovy injection, certain liver disease.
Quick links
Ask Anything About SemaglutideType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Semaglutide in Short
- Drug class GLP-1 Receptor Agonist How the FDA classifies it
What it treatsSemaglutide is sold under different brand names, and each is approved for different uses. Ozempic injection is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
- How you get it Prescription only
- Comes asInjection and tabletAvailable strengths
Injection (under the skin)
- 0.25 mg/0.5 mL
- 0.5 mg/0.5 mL
- 1 mg/0.5 mL
- 1.7 mg/0.75 mL
- 2.4 mg/0.75 mL
- 7.2 mg/0.75 mL
See forms and strengths+ 10 more strengthsShow fewer strengths
Injection (under the skin), amount in each mL
- 0.68 mg/mL
- 1.34 mg/mL
- 2.68 mg/mL
Tablet (by mouth)
- 1.5 mg
- 3 mg
- 4 mg
- 7 mg
- 9 mg
- 14 mg
- 25 mg
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Rybelsus (tablet); Semaglutide (tablet)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- Supplements and herbs252 interact 2 major, 210 moderate and 40 minor
- What pharmacies pay
- Brand names$332.00 to $653.33 per mL (injections)Wegovy and Ozempic
- Tablets, brand name: $33.16 to $43.47 each
- Generic launch2031 to 2032 Rybelsus: 2032 to 2033 Our estimate for the first generic of Ozempic
The Pharmacist’s Take
Semaglutide (Ozempic, Wegovy, Rybelsus) mimics the gut hormone GLP-1 to boost insulin release, slow the stomach and curb appetite, and since reaching the U.S. market around 2017 it has become widely prescribed for type 2 diabetes (with heart and kidney benefits), weight management, heart risk reduction and, as Wegovy injection, MASH (fatty liver with scarring). Most people tolerate it, though nausea, diarrhea or constipation are common early and usually ease. Its boxed warning covers thyroid C-cell tumors seen in rodents (unknown in people), so it is off-limits with a personal or family history of medullary thyroid cancer or MEN 2 (an inherited gland condition).
Key Takeaways From the HelloPharmacist Team
- Inject Ozempic or Wegovy once a week on the same day; take tablets each morning on an empty stomach, then wait 30 minutes.
- Stop it and call your doctor for severe stomach pain reaching your back; face or throat swelling needs emergency care.
- Sip fluids through any bout of vomiting or diarrhea, because dehydration on semaglutide can injure the kidneys.
- Never combine Ozempic, Wegovy or Rybelsus with each other or another GLP-1 medicine, and never share a pen.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Semaglutide.
Semaglutide caused thyroid tumors in rodents, and it is not known whether it does so in people. You should not use it if you or a close relative has had medullary thyroid carcinoma (a type of thyroid cancer) or if you have MEN 2, a genetic condition. Tell your doctor right away about a lump in your neck, trouble swallowing, trouble breathing or hoarseness that does not go away. Routine blood tests or thyroid ultrasounds are of uncertain value for catching these tumors early.
Patient Information Guide for Semaglutide
What It’s Used For
Semaglutide products are approved for different uses depending on the brand and form.
- Ozempic injection: improves blood sugar control in adults with type 2 diabetes.
- Ozempic injection: lowers risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
- Ozempic injection: lowers risk of sustained eGFR decline, end-stage kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
- Rybelsus and Ozempic tablets: improve blood sugar control in adults with type 2 diabetes and lower cardiovascular event risk in those at high risk.
- Wegovy injection and tablets: lower cardiovascular event risk in adults with established cardiovascular disease and obesity or overweight.
- Wegovy injection and tablets: reduce excess body weight and maintain weight loss in adults with obesity, or overweight plus a weight-related condition.
- Wegovy injection: also for weight reduction in children 12 and older with obesity.
- Wegovy injection: treats noncirrhotic MASH with moderate to advanced liver fibrosis in adults (accelerated approval).
How It Works
Semaglutide is a GLP-1 analogue that binds to and activates GLP-1 receptors. GLP-1 helps regulate appetite and calorie intake, and its receptors are found in brain areas that control appetite. Semaglutide also boosts insulin release and lowers glucagon when blood sugar is high. How it lowers cardiovascular risk and treats MASH is not fully understood.
Drug Class
Drug Class
- GLP-1 Receptor Agonist
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- GLP-1 Receptor Agonist
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Glucagon-like Peptide-1 (GLP-1) Agonists
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Semaglutide in the FDA’s index.
From our Patient Information GuideSemaglutide is a GLP-1 analogue that binds to and activates GLP-1 receptors. GLP-1 helps regulate appetite and calorie intake, and its receptors are found in brain areas that control appetite. Read How Semaglutide Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Glucagon-Like Peptide 1
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Glucagon-like peptide-1 (GLP-1) analogues
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Semaglutide is taken in different ways depending on the product. Doses start low and rise slowly to reduce stomach side effects.
- Ozempic and Wegovy injections: once weekly under the skin, with or without food, same day each week.
- Wegovy tablets: once daily in the morning on an empty stomach with plain water, then wait 30 minutes before food, drinks or other pills.
- Ozempic missed dose: take it within 5 days; after that, skip it and resume your regular day.
Follow your prescriber and the product label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Wegovy Injection
Weight loss and heart risk reduction
Adults and children 12 years and older · Weeks 1 through 4 Starting dose 0.25 mg once a week
- 0.25 mg subcutaneously once weekly
Dosage escalation, weeks 5 through 8 (all approved indications) Dose 0.5 mg once weekly
- 0.5 mg subcutaneously once weekly
Good to know
If a dose is not tolerated, consider delaying escalation for 4 weeks
Adults and children 12 years and older · Weeks 9 through 12 Dose 1 mg once weekly
- 1 mg subcutaneously once weekly
Dosage escalation, weeks 13 through 16 (all approved indications) Dose 1.7 mg once weekly
- 1.7 mg subcutaneously once weekly
Adults with heart disease and obesity or overweight · Week 17 onward Usual dose 2.4 mg once a week
- 2.4 mg (recommended) or 1.7 mg once weekly
Adults with obesity or overweight · Week 17 onward Usual dose 2.4 mg once a week Highest dose 7.2 mg once a week
Step by step
- 1.7 mg or 2.4 mg (recommended) subcutaneously once weekly
- May be increased after at least 4 weeks on 2.4 mg if more weight reduction is needed
Children 12 years and older with obesity · Week 17 onward Usual dose 2.4 mg once a week
- 2.4 mg (recommended) or 1.7 mg once weekly
Fatty liver disease with scarring (MASH)
For adults · Maintenance dosage
Usual dose 2.4 mg once a week
- 2.4 mg injected subcutaneously once weekly
- If not tolerated, may be decreased to 1.7 mg once weekly, with reescalation to 2.4 mg considered
Ozempic
Type 2 diabetes
Adults · Starting dose Starting dose 0.25 mg once a week
- 0.25 mg injected subcutaneously once weekly for 4 weeks, then 0.5 mg once weekly
Adults · Maintenance dose Highest dose 2 mg once a week
- 0.5 mg, 1 mg, or 2 mg subcutaneously once weekly based on glycemic control
- Increase to 1 mg after at least 4 weeks on 0.5 mg, to 2 mg after at least 4 weeks on 1 mg
What a maintenance dose is: The regular ongoing dose taken to keep a steady, effective amount of medicine in the body over time.
Adults with chronic kidney disease · Maintenance dose Usual dose 1 mg once a week
- 1 mg once weekly after at least 4 weeks on the 0.5 mg dosage
Rybelsus and Ozempic
Rybelsus tablets, days 1 to 30 starting dosage
For adults taking Rybelsus · Days 1 to 30
Starting dose 3 mg once a day
- 3 mg orally once daily for 30 days (not effective for glycemic control)
Rybelsus tablets, days 31 to 60
For adults taking Rybelsus · Days 31 to 60 Usual dose 7 mg once a day
Rybelsus tablets, day 61 or thereafter
For adults taking Rybelsus · Day 61 onward
Usual dose 7 mg once a day
Highest dose 14 mg once a day
Step by step
- 7 mg orally once daily if no additional glycemic control is needed
- 14 mg once daily if additional control is needed
Ozempic tablets, days 1 to 30 starting dosage
For adults taking Ozempic tablets · Days 1 to 30
Starting dose 1.5 mg once a day
- 1.5 mg orally once daily for 30 days (not effective for glycemic control)
Ozempic tablets, days 31 to 60
For adults taking Ozempic tablets · Days 31 to 60 Usual dose 4 mg once a day
Ozempic tablets, day 61 or thereafter
For adults taking Ozempic tablets · Day 61 onward
Usual dose 4 mg once a day
Highest dose 9 mg once a day
Step by step
- 4 mg orally once daily if no additional glycemic control is needed
- 9 mg once daily if additional control is needed
Wegovy Tablets
Weight loss and heart risk reduction
Side Effects
The most common side effects involve the stomach and are often worst when starting or raising the dose.
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach pain
- Headache
- Tiredness
- Indigestion or burping
- Indigestion, bloating and burping
- Dizziness and hair loss
- Skin tingling or sensitivity (dysesthesia)
When to get medical help
- Persistent or severe stomach pain, sometimes spreading to the back, with or without vomiting (possible pancreatitis). Stop the medicine and call your doctor.
- A lump in the neck, trouble swallowing, trouble breathing or lasting hoarseness (possible thyroid tumor).
- Swelling of the face or throat, or trouble breathing (serious allergic reaction).
- Severe or ongoing vomiting or diarrhea leading to dehydration, which can harm the kidneys.
- Signs of gallbladder problems, such as gallstones or inflamed gallbladder.
- Signs of low blood sugar, especially if you also use insulin or a sulfonylurea.
- Vision changes if you have diabetic retinopathy (eye damage from diabetes).
Warnings and Precautions
- Thyroid tumors (boxed warning): seen in rodents; human risk unknown. Not for people with a history of MTC or MEN 2.
- Pancreatitis: stop and call your doctor if you have severe, persistent stomach pain.
- Gallbladder disease: gallstones and gallbladder inflammation have been reported.
- Kidney injury: can follow dehydration from vomiting or diarrhea.
- Low blood sugar: higher risk with insulin or sulfonylureas.
- Diabetic retinopathy: more complications were seen in a trial; people with this history should be monitored.
- Anesthesia: slowed stomach emptying may lead to aspiration; tell providers before procedures.
- Pen sharing: never share an Ozempic pen.
Interactions
Semaglutide can affect how other medicines work or add to their effects.
- Insulin or sulfonylureas: raises low blood sugar risk, so doses may need lowering.
- Other GLP-1 medicines or semaglutide products: not recommended together.
- Oral medicines: slowed stomach emptying may change absorption; use caution.
- Wegovy tablets: wait 30 minutes before taking other oral medicines.
Interactions Listed in the FDA-Approved Label
From the Semaglutide prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Insulin secretagogues (e.g., sulfonylureas) or insulinWhat happensUsing Ozempic with these may increase the risk of hypoglycemia, including severe hypoglycemia.What to doWhen starting Ozempic, consider reducing the dose of the insulin secretagogue (such as sulfonylureas) or insulin.
-
Oral medicationsWhat happensOzempic delays gastric emptying and may affect absorption of oral medications taken at the same time; trials showed no clinically relevant effect on absorption.What to doUse caution when oral medications are taken with Ozempic.
Read the label’s full interactions text
7 DRUG INTERACTIONS Oral Medications: OZEMPIC delays gastric emptying. May impact absorption of concomitantly administered oral medications. Use with caution. 7.1 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin OZEMPIC stimulates insulin release in the presence of elevated blood glucose concentrations. Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia. When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia. 7.2 Oral Medications OZEMPIC causes a delay of gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications. In clinical pharmacology trials, semaglutide did not affect the absorption of orally administered medications to any clinically relevant degree. Nonetheless, caution should be exercised when oral medications are concomitantly administered with OZEMPIC.
7.1 Concomitant Use with an Insulin Secretagogue (e.g., Sulfonylurea) or with Insulin OZEMPIC stimulates insulin release in the presence of elevated blood glucose concentrations. Patients receiving OZEMPIC in combination with an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia. When initiating OZEMPIC, consider reducing the dose of concomitantly administered insulin secretagogue (such as sulfonylureas) or insulin to reduce the risk of hypoglycemia.
7.2 Oral Medications OZEMPIC causes a delay of gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use with a personal or family history of MTC or MEN 2.
- Do not use after a serious allergic reaction to semaglutide or its ingredients.
- Tell your doctor about pancreatitis, diabetic retinopathy, severe gastroparesis or gallbladder problems.
- Pregnancy: Wegovy may harm a baby; stop when pregnancy is recognized and at least 2 months before planning pregnancy.
- Breastfeeding is not recommended with Wegovy tablets.
- Wegovy injection is approved for children 12 and older with obesity; Wegovy tablets and the 7.2 mg injection have not been established in children.
- Ozempic is not for type 1 diabetes.
Overdose
Overdoses of GLP-1 medicines have caused severe nausea, severe vomiting and severe low blood sugar. Treatment is supportive, based on symptoms. Call Poison Help at 1-800-222-1222. Because semaglutide has a long half-life of about a week, you may need extended observation and treatment.
Half-Life and How Your Body Processes It
Injected semaglutide is about 89% absorbed and peaks in 1 to 3 days. Wegovy tablets use an absorption helper (SNAC), are about 1% to 2% absorbed, and peak in about 1 hour. Semaglutide is heavily bound to albumin and has a half-life of about 1 week, so it stays in the body for 5 to 7 weeks after the last dose. It is broken down by the body and cleared through urine and feces.
Storage
• Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze WEGOVY and do not use if it has been frozen. Store the WEGOVY prefilled single-dose pen or single-dose syringe in the refrigerator from 2°C to 8°C (36°F to 46°F).
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Semaglutide
From the licensed clinical database we use, rolled up per supplement, most serious first.252 supplements and herbal products have documented interactions with Semaglutide in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 2Major
- 210Moderate
- 40Minor
- ACTIVATED CHARCOALMajor
- SIBERIAN COCKLEBURMajor
- ACAIModerate
- AFRICAN WILD POTATOModerate
- AGARICUS MUSHROOMModerate
- AGMATINEModerate
- AGRIMONYModerate
- ALFALFAModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrients Semaglutide May Deplete
Nutrients Semaglutide has been linked with lower levels of, from the licensed clinical database we use.Semaglutide has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.
Semaglutide: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Semaglutide — the kind of thing our pharmacy team would talk through with you at the counter.
What happens if I miss a dose of Ozempic?
How should I take Wegovy tablets?
What side effects should I expect with semaglutide?
When should I call my doctor about semaglutide?
Can I take semaglutide with insulin or other diabetes medicines?
Is semaglutide safe during pregnancy?
Is semaglutide available over the counter?
When was semaglutide first available?
Who makes semaglutide?
What is the brand name of semaglutide?
What is the generic name of Rybelsus?
What drug class is semaglutide?
What strengths does semaglutide come in?
How much does semaglutide cost?
Is there a semaglutide shortage?
Where can I read the semaglutide prescribing information (package insert)?
Can you crush semaglutide?
Is semaglutide gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Semaglutide
Skip the scrolling. Ask in your own words and get an answer from Semaglutide’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Semaglutide’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Semaglutide on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Semaglutide Forms and Strengths (How It Comes)
Semaglutide comes in 2 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Semaglutide inactive ingredients by manufacturer.
Injection
How this form is used
- Ozempic injection is used for blood sugar control in adults with type 2 diabetes.
- Ozempic injection lowers major cardiovascular event risk in adults with type 2 diabetes and established cardiovascular disease, and kidney risks in those with chronic kidney disease.
- Wegovy injection is used for weight reduction in adults and in children 12 and older with obesity.
- Wegovy injection is also used for cardiovascular risk reduction and for MASH with moderate to advanced liver fibrosis in adults.
- Ozempic is injected under the skin once a week, with or without food.
- Wegovy injection is given under the skin once a week, on the same day each week.
- Ozempic: if a dose is missed, take it within 5 days; otherwise skip it and resume the usual day.
- Rotate injection sites, and do not use if the solution is cloudy, colored or has particles.
Show 4 more strengths Show fewer strengths
Tablet
How this form is used
- Rybelsus and Ozempic tablets are used for blood sugar control in adults with type 2 diabetes.
- Rybelsus and Ozempic tablets lower major cardiovascular event risk in adults with type 2 diabetes at high risk for these events.
- Wegovy tablets are used for weight reduction and cardiovascular risk reduction in adults.
- Wegovy tablets are taken once daily on an empty stomach in the morning with up to 4 ounces of plain water.
- Swallow Wegovy tablets whole; do not split, crush, chew or dissolve them.
- Wait at least 30 minutes after a Wegovy tablet before eating, drinking or taking other oral medicines.
Show 1 more strength Show fewer strengths
Semaglutide on the U.S. Market: Products, Makers and Brands
How Semaglutide appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
2 companies list 24 Semaglutide product records with the FDA, mostly as injection, tablet; the earliest marketing or approval year on record is 2017. Brand names in the directory today include Rybelsus, Ozempic and Wegovy; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (59) · Unfinished injection, solution (24) · Unfinished tablet (3) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Semaglutide Is Used (Medicaid Data)
How many Semaglutide prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Semaglutide prescribed? Of the 1,682 medications we measure, Semaglutide ranks #31 by Medicaid prescriptions — more than 98% of them.
Utilization by Semaglutide product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
0.25 MG, 0.5 MG Dose 3 ML semaglutide 0.68 MG/ML Pen Injector Most dispensed
2 of 4 listed NDCs had Medicaid claims. RxNorm 2619152
3 ML semaglutide 2.68 MG/ML Pen Injector
1 of 5 listed NDCs had Medicaid claims. RxNorm 2599362
3 ML semaglutide 1.34 MG/ML Pen Injector
1 of 3 listed NDCs had Medicaid claims. RxNorm 2398841
0.75 ML semaglutide 3.2 MG/ML Auto-Injector
1 of 2 listed NDCs had Medicaid claims. RxNorm 2554102
0.5 ML semaglutide 1 MG/ML Auto-Injector
1 of 2 listed NDCs had Medicaid claims. RxNorm 2553601
0.5 ML semaglutide 0.5 MG/ML Auto-Injector
1 of 5 listed NDCs had Medicaid claims. RxNorm 2553501
0.5 ML semaglutide 2 MG/ML Auto-Injector
1 of 2 listed NDCs had Medicaid claims. RxNorm 2553802
0.75 ML semaglutide 2.27 MG/ML Auto-Injector
1 of 2 listed NDCs had Medicaid claims. RxNorm 2553901
semaglutide 14 MG Oral Tablet
1 of 4 listed NDCs had Medicaid claims. RxNorm 2200644
semaglutide 7 MG Oral Tablet
1 of 4 listed NDCs had Medicaid claims. RxNorm 2200656
semaglutide 3 MG Oral Tablet
1 of 7 listed NDCs had Medicaid claims. RxNorm 2200652
Other Semaglutide products: packs and listings not matched to one strength and form
1 of 339 listed NDCs had Medicaid claims.
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 13 of the 379 listed Semaglutide NDCs had Medicaid claims.
Compare Semaglutide Products
A representative set of FDA-listed product records for Semaglutide — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Injection | ||||
| 0.25 mg/0.5 mL | Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 0.68 mg/mL | Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 1.34 mg/mL | Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 2.68 mg/mL | Subcutaneous | A-S Medication Solutions | NDA | View NDC → |
| 0.25 mg/0.5 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 0.5 mg/0.5 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 0.68 mg/mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 1 mg/0.5 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 1.34 mg/mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 1.7 mg/0.75 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 2.4 mg/0.75 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 2.68 mg/mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 3.2 mg/mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View label ↗ |
| 7.2 mg/0.75 mL | Subcutaneous | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 💊Tablet | ||||
| 1.5 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP × 2 listings | NDA | View NDC → |
| 3 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 4 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP × 2 listings | NDA | View NDC → |
| 7 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 9 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP × 2 listings | NDA | View NDC → |
| 14 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
| 25 mg | Oral | Novo Nordisk Pharmaceutical Industries, LP | NDA | View NDC → |
Showing 24 of 24 products — FDA National Drug Code Directory. See every product, package size and price: browse all 24 Semaglutide NDCs →
Semaglutide Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Semaglutide — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Semaglutide are nausea, vomiting, diarrhoea; about 50% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Semaglutide in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Semaglutide FDA Approval History
How Semaglutide went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Semaglutide was first approved by the FDA in 2017 (Brand: OZEMPIC · Novo). It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Semaglutide Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Semaglutide recalls since July 2021.
✅No Semaglutide recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Semaglutide in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 3
- Strengths
- 17
- Forms in current FDA listings
- 3 of 3
RxCUI 1991302 -
Dose form (SCDF) Auto-InjectorIn current FDA listings
RxCUI 2553500Its 6 strengths (SCD)-
0.5 mL semaglutide 0.5 mg/mL
RxCUI 2553501 -
0.5 mL semaglutide 1 mg/mL
RxCUI 2553601 -
0.5 mL semaglutide 2 mg/mL
RxCUI 2553802 -
0.75 mL semaglutide 2.27 mg/mL
RxCUI 2553901 -
0.75 mL semaglutide 3.2 mg/mL
RxCUI 2554102 -
0.75 mL semaglutide 9.6 mg/mL
RxCUI 2739768
-
0.5 mL semaglutide 0.5 mg/mL
-
Dose form (SCDF) Pen InjectorIn current FDA listings
RxCUI 1991305Its 4 strengths (SCD)-
0.25 mg, 0.5 mg Dose 3 mL semaglutide 0.68 mg/mL
RxCUI 2619152 -
3 mL semaglutide 1.34 mg/mL
RxCUI 2398841 -
3 mL semaglutide 2.68 mg/mL
RxCUI 2599362 -
3 mL semaglutide 3.2 mg/mL
RxCUI 2745801
-
0.25 mg, 0.5 mg Dose 3 mL semaglutide 0.68 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Semaglutide Supply and Shortage Status
Whether Semaglutide is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Semaglutide is not in shortage right now; the FDA has 3 past shortage records for it.
✅No current shortage of Semaglutide on recordA company has told the FDA it is discontinuing one version of Semaglutide. See which products it covers →
Source: openFDA, from the FDA Drug Shortages database.
What Semaglutide Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Semaglutide: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.
For brand-name Ozempic, the 0.68 mg/mL injection, pharmacies paid an average of $332.04 per mL as of Nov 18, 2026, up 3% from $322.38 a year earlier.
- What pharmacies pay now
- $332.04
- per mL, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $332.02 on Oct 21, 2026
- Last 12 months
- Up 3%
- from $322.38 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $300.34 to $332.04
- per mL
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $332.04 |
| Oct 2026 | $332.02 |
| Sep 2026 | $331.99 |
| Aug 2026 | $331.97 |
| Jul 2026 | $331.97 |
| Jun 2026 | $331.98 |
| May 2026 | $332.00 |
| Apr 2026 | $332.02 |
| Mar 2026 | $332.02 |
| Feb 2026 | $332.02 |
| Jan 2026 | $332.02 |
| Dec 2025 | $322.35 |
| Nov 2025 | $322.38 |
| Oct 2025 | $322.33 |
| Sep 2025 | $322.31 |
| Aug 2025 | $322.29 |
| Jul 2025 | $322.25 |
| Jun 2025 | $322.19 |
| May 2025 | $322.21 |
| Apr 2025 | $321.22 |
| Mar 2025 | $321.22 |
| Feb 2025 | $321.22 |
| Jan 2025 | $321.22 |
| Dec 2024 | $311.86 |
| Nov 2024 | $311.81 |
| Oct 2024 | $311.82 |
| Sep 2024 | $311.81 |
| Aug 2024 | $311.81 |
| Jul 2024 | $311.81 |
| Jun 2024 | $311.77 |
| May 2024 | $311.83 |
| Apr 2024 | $310.85 |
| Mar 2024 | $310.85 |
| Feb 2024 | $310.85 |
| Jan 2024 | $310.85 |
| Dec 2023 | $300.34 |
| Nov 2023 | $300.34 |
See all 16 prices in a table
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Injection · Subcutaneous | 0.25 mg/0.5 mL | Wegovy (brand) | $653.33 per mL | NDC details & price history |
| Injection · Subcutaneous | 0.5 mg/0.5 mL | Wegovy (brand) | $653.05 per mL | NDC details & price history |
| Injection · Subcutaneous | 0.68 mg/mL | Ozempic (brand) | $332.04 per mL | NDC details & price history |
| Injection · Subcutaneous | 1 mg/0.5 mL | Wegovy (brand) | $653.08 per mL | NDC details & price history |
| Injection · Subcutaneous | 1.34 mg/mL | Ozempic (brand) | $332.00 per mL | NDC details & price history |
| Injection · Subcutaneous | 1.7 mg/0.75 mL | Wegovy (brand) | $435.40 per mL | NDC details & price history |
| Injection · Subcutaneous | 2.4 mg/0.75 mL | Wegovy (brand) | $435.31 per mL | NDC details & price history |
| Injection · Subcutaneous | 2.68 mg/mL | Ozempic (brand) | $332.05 per mL | NDC details & price history |
| Injection · Subcutaneous | 7.2 mg/0.75 mL | Wegovy (brand) | $435.06 per mL | NDC details & price history |
| Tablet · Oral | 1.5 mg | Ozempic (brand) | $33.16 per tablet | NDC details & price history |
| Tablet · Oral | 3 mg | Rybelsus (brand) | $33.19 per tablet | NDC details & price history |
| Tablet · Oral | 4 mg | Ozempic (brand) | $33.19 per tablet | NDC details & price history |
| Tablet · Oral | 7 mg | Rybelsus (brand) | $33.19 per tablet | NDC details & price history |
| Tablet · Oral | 9 mg | Ozempic (brand) | $33.19 per tablet | NDC details & price history |
| Tablet · Oral | 14 mg | Rybelsus (brand) | $33.19 per tablet | NDC details & price history |
| Tablet · Oral | 25 mg | Wegovy (brand) | $43.47 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Semaglutide Brand Names
Semaglutide has 3 brand names on record: Rybelsus, Ozempic and Wegovy. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Semaglutide: Manufacturers and Labelers
2 companies list Semaglutide products with the FDA. By number of product records, the largest are Novo Nordisk Pharmaceutical Industries, LP, A-S Medication Solutions. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Semaglutide Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Novo Nordisk is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →